• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利那格列汀及其合成杂质的生物安全性研究与LC-PDA同步测定

Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA.

作者信息

Heleno Ferreira Raquel Balestri, Duarte Jonathaline Apollo, Ferreira Flávio Dias, de Oliveira Luis Flávio Souza, Machado Michel Mansur, Malesuik Marcelo Donadel, Paula Fávero Reisdorfer, Steppe Martin, Schapoval Elfrides Eva Shermann, Paim Clésio Soldateli

机构信息

Laboratório de Pesquisa em Desenvolvimento e Controle de Qualidade, Universidade Federal do Pampa, Uruguaiana, RS, Brazil.

Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Pampa, Uruguaiana, RS, Brazil.

出版信息

J Anal Methods Chem. 2019 Mar 3;2019:7534609. doi: 10.1155/2019/7534609. eCollection 2019.

DOI:10.1155/2019/7534609
PMID:30944754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6421826/
Abstract

A stability-indicating LC method was developed for quantification of linagliptin (LGT) and three synthetic impurities. The method utilizes a Thermo Scientific® RP-8 column (100 mm × 4.6 mm; 5 m) with the PDA detector for quantitation of impurities. A mixture of 0.1% formic acid with pH 3.5 (A) and acetonitrile (B) was used as the mobile phase at a flow rate of 0.6 mL·min with gradient elution. The percentage of mobile phase B increases from 30% to 70% over 5 min and decreases from 70% to 30% between 5 and 8 min. The method was validated according to International Council for Harmonization (ICH) guidelines. The LOD values obtained were 0.0171 g·mL and 0.015 g·mL for LGT and impurities, respectively. The LOQ values were 0.06 g·mL for LGT and impurities. In all cases, the correlation coefficients of LGT and impurities were >0.999, showing the linearity of the method. The % recovery of the LGT and added impurity were in the range of 92.92-99.79%. The precision of the method showed values less than 1.47% for LGT and less than 4.63% for impurities. The robustness was also demonstrated by small modifications in the chromatographic conditions. The selectivity was evidenced because the degradation products formed in stress conditions did not interfere in the determination of LGT and impurities. Toxicity prediction studies suggested toxicity potential of the impurities, which was confirmed using biological safety studies in vitro.

摘要

开发了一种用于定量利格列汀(LGT)和三种合成杂质的稳定性指示液相色谱法。该方法采用赛默飞世尔科技®RP - 8柱(100 mm×4.6 mm;5 µm),配备PDA检测器用于杂质定量。以0.1%甲酸(pH 3.5)与乙腈的混合物(A)作为流动相,流速为0.6 mL·min,采用梯度洗脱。流动相B的百分比在5分钟内从30%增加到70%,在5至8分钟之间从70%降至30%。该方法根据国际协调理事会(ICH)指南进行了验证。LGT和杂质的检测限(LOD)值分别为0.0171 μg·mL和0.015 μg·mL。LGT和杂质的定量限(LOQ)值均为0.06 μg·mL。在所有情况下,LGT和杂质的相关系数均>0.999,表明该方法具有线性。LGT和添加杂质的回收率在92.92 - 99.79%范围内。该方法的精密度显示,LGT的值小于1.47%,杂质的值小于4.63%。通过对色谱条件的微小改变也证明了该方法的稳健性。选择性得到了证明,因为在强制条件下形成的降解产物不会干扰LGT和杂质的测定。毒性预测研究表明杂质具有潜在毒性,这在体外生物安全性研究中得到了证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/947621a50407/JAMC2019-7534609.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/595156bcce92/JAMC2019-7534609.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/fd013a4eb987/JAMC2019-7534609.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/f56a9bac8e71/JAMC2019-7534609.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/947621a50407/JAMC2019-7534609.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/595156bcce92/JAMC2019-7534609.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/fd013a4eb987/JAMC2019-7534609.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/f56a9bac8e71/JAMC2019-7534609.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/6421826/947621a50407/JAMC2019-7534609.004.jpg

相似文献

1
Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA.利那格列汀及其合成杂质的生物安全性研究与LC-PDA同步测定
J Anal Methods Chem. 2019 Mar 3;2019:7534609. doi: 10.1155/2019/7534609. eCollection 2019.
2
Empagliflozin: Validation of Stability-Indicating LC Method and in silico Toxicity Studies.恩格列净:稳定性指示 LC 方法的验证和计算机毒理学研究。
J Chromatogr Sci. 2024 Feb 2;62(2):132-139. doi: 10.1093/chromsci/bmac106.
3
Development and Validation of a Stability-Indicating LC-Method for the Simultaneous Estimation of Levodropropizine, Chloropheniramine, Methylparaben, Propylparaben, and Levodropropizine Impurities.一种同时测定左羟丙哌嗪、氯苯那敏、对羟基苯甲酸甲酯、对羟基苯甲酸丙酯及左羟丙哌嗪杂质的稳定性指示液相色谱法的开发与验证
Sci Pharm. 2013 Jan-Mar;81(1):139-50. doi: 10.3797/scipharm.1210-18. Epub 2012 Nov 17.
4
Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation.用于原料药和药物制剂中屈他维林杂质测定的稳定性指示反相高效液相色谱法的开发与验证
Sci Pharm. 2013 Oct 21;82(1):99-115. doi: 10.3797/scipharm.1309-06. Print 2014 Jan-Mar.
5
A new validated liquid chromatographic method for the determination of loratadine and its impurities.一种新的经过验证的用于测定氯雷他定及其杂质的液相色谱方法。
Sci Pharm. 2011 Apr-Jun;79(2):277-91. doi: 10.3797/scipharm.1012-13. Epub 2011 Feb 12.
6
Development and Validation of a New Stability-Indicating RP-UPLC Method for the Quantitative Determination of Bromfenac Sodium and Its Impurities in an Ophthalmic Dosage Form.一种用于定量测定眼用剂型中溴芬酸钠及其杂质的新型稳定性指示反相超高效液相色谱法的开发与验证
J Chromatogr Sci. 2016 Oct 17;54(9):1514-1521. doi: 10.1093/chromsci/bmw089.
7
Development of an effective novel validated stability-indicating HPLC method for the resolution of brivaracetam stereoisomeric impurities.开发一种有效的新型经验证的 HPLC 方法,用于拆分布瓦西坦对映异构体杂质。
Chirality. 2020 Sep;32(9):1208-1219. doi: 10.1002/chir.23269. Epub 2020 Jul 13.
8
Development and validation of an UPLC method for rapid determination of ibuprofen and diphenhydramine citrate in the presence of impurities in combined dosage form.一种用于快速测定复方制剂中存在杂质情况下布洛芬和枸橼酸苯海拉明的超高效液相色谱法的开发与验证
J Chromatogr Sci. 2011 Apr;49(4):281-6. doi: 10.1093/chrsci/49.4.281.
9
Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.开发并验证一种用于快速同时测定达芦那韦原料药中六种工艺相关杂质的选择性、灵敏且具有稳定性指示能力的超高效液相色谱-串联质谱法。
J Pharm Biomed Anal. 2016 Sep 5;128:141-148. doi: 10.1016/j.jpba.2016.05.026. Epub 2016 May 18.
10
RP-LC gradient elution method for simultaneous determination of thiocolchicoside, aceclofenac and related impurities in tablet formulation.RP-LC梯度洗脱法同时测定片剂中硫代秋水仙碱、醋氯芬酸及相关杂质
J Pharm Bioallied Sci. 2014 Oct;6(4):246-52. doi: 10.4103/0975-7406.142955.

引用本文的文献

1
Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques.通过质谱技术鉴定利格列汀的降解产物并进行结构表征。
Int J Mol Sci. 2024 Feb 23;25(5):2591. doi: 10.3390/ijms25052591.
2
Metabolism and Chemical Degradation of New Antidiabetic Drugs (Part II): A Review of Analytical Approaches for Analysis of Gliptins.新型抗糖尿病药物的代谢与化学降解(第二部分):格列汀类药物分析方法综述
Biomedicines. 2023 Jul 11;11(7):1956. doi: 10.3390/biomedicines11071956.
3
Development of depot PLGA-based implant of Linagliptin: Sustained release and glycemic control.

本文引用的文献

1
Identification, isolation, characterization, and UHPLC quantification of potential genotoxic impurities in linagliptin.来格列汀中潜在遗传毒性杂质的鉴定、分离、结构表征和 UHPLC 定量分析。
J Sep Sci. 2018 Nov;41(21):3985-3994. doi: 10.1002/jssc.201800623. Epub 2018 Sep 12.
2
Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII.采用二水平析因设计开发测定利格列汀在盐酸二甲双胍存在下的降解产物的反相高效液相色谱稳定性指示方法;杂质VII、VIII和IX的鉴定以及杂质VII的合成。
Sci Pharm. 2017 Jun 27;85(3):25. doi: 10.3390/scipharm85030025.
3
基于聚乳酸-羟基乙酸共聚物(PLGA)的利那格列汀长效植入剂的研发:缓释与血糖控制。
Saudi Pharm J. 2023 Apr;31(4):499-509. doi: 10.1016/j.jsps.2023.02.002. Epub 2023 Feb 13.
Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin.
抗糖尿病药物利格列汀工艺相关杂质的合成与表征
Molecules. 2016 Aug 9;21(8):1041. doi: 10.3390/molecules21081041.
4
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes.恩格列净(一种钠-葡萄糖协同转运蛋白2抑制剂)单独使用或与利格列汀(一种二肽基肽酶-4抑制剂)联合使用,可在一种新型非酒精性脂肪性肝炎和糖尿病小鼠模型中预防脂肪性肝炎。
Diabetol Metab Syndr. 2016 Jul 26;8:45. doi: 10.1186/s13098-016-0169-x. eCollection 2016.
5
Simultaneous determination of linagliptin and metformin by reverse phase-high performance liquid chromatography method: An application in quantitative analysis of pharmaceutical dosage forms.采用反相高效液相色谱法同时测定利格列汀和二甲双胍:在药物剂型定量分析中的应用
J Adv Pharm Technol Res. 2015 Jan-Mar;6(1):25-8. doi: 10.4103/2231-4040.150368.
6
Automated and reproducible read-across like models for predicting carcinogenic potency.用于预测致癌潜力的自动化且可重复的类似读码框模型。
Regul Toxicol Pharmacol. 2014 Oct;70(1):370-8. doi: 10.1016/j.yrtph.2014.07.010. Epub 2014 Jul 15.
7
Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets.利格列汀与二甲双胍的固定剂量复方制剂与利格列汀和二甲双胍单独片剂联合给药具有生物等效性。
Int J Clin Pharmacol Ther. 2014 Jul;52(7):537-48. doi: 10.5414/CP201960.
8
Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride using High Performance Liquid Chromatography.分光光度法测定与盐酸二甲双胍二元混合物中的利那格列汀以及使用高效液相色谱法同时测定利那格列汀和盐酸二甲双胍
Int J Biomed Sci. 2013 Mar;9(1):41-7.
9
Liquid chromatographic determination of linagliptin in bulk, in plasma and in its pharmaceutical preparation.液相色谱法测定利格列汀原料药、血浆及药物制剂中的含量。
Int J Biomed Sci. 2012 Sep;8(3):209-14.
10
Linagliptin: a review of its use in the management of type 2 diabetes mellitus.利拉鲁肽:在 2 型糖尿病管理中的应用评价。
Drugs. 2012 Sep 10;72(13):1793-824. doi: 10.2165/11209570-000000000-00000.